文献速递头颈与中枢神经肿瘤乳腺癌骨软组织肉瘤与黑色素瘤

巴西TP53 p.R337H突变携带者李佛美尼综合征中甲状腺癌的发生频率

Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
PubMed 文献 · JAMA Oncol · 2017-01-01

该研究回顾性分析了巴西A.C. Camargo癌症中心193例携带TP53 p.R337H突变的李佛美尼综合征患者的病历资料,其中101例患癌,甲状腺癌患病率为10.9%(3男8女),平均诊断年龄44岁,均为乳头状癌。作者认为甲状腺癌可能与巴西创始人TP53 p.R337H突变相关,该基因型/表型关联知识有助于调整针对这些特定携带者的李佛美尼综合征筛查建议。

要点

  • 甲状腺癌患者平均诊断年龄44岁,均为乳头状癌,其中2例为滤泡亚型。
  • 甲状腺癌患者中最常见的其他癌症为乳腺癌(5例)和软组织肉瘤(2例)。

核心结论

  • 甲状腺癌可能与巴西创始人TP53 p.R337H突变相关,该基因型/表型关联知识有助于调整针对这些特定携带者的李佛美尼综合征筛查建议。

研究设计与样本

  • 回顾性分析巴西A.C. Camargo癌症中心肿瘤遗传学系数据库中193例携带胚系TP53 p.R337H突变的李佛美尼综合征患者的病历资料,并分析巴西携带者的肿瘤谱数据。

主要发现

  • 193例TP53 p.R337H突变携带者来自58个家族,其中101例患癌,甲状腺癌患病率为10.9%(3男8女)。
  • 甲状腺癌平均诊断年龄为44岁(中位数[标准差]43[14.77]岁)。
  • 所有甲状腺癌病例组织学分类均为乳头状癌,其中2例为滤泡亚型。
  • 甲状腺癌患者中最常见的其他癌症为乳腺癌(5例)和软组织肉瘤(2例)。

临床怎么用

  • 作者认为关于该基因型/表型关联的知识有助于调整针对巴西TP53 p.R337H突变携带者的李佛美尼综合征筛查建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Li Fraumeni syndrome (LFS) is associated with a wide variety of tumors; nevertheless, thyroid carcinoma has not been evaluated in this syndrome. Due to the Brazilian founder mutation p.R337H, some tumors that have not been described in the classic LFS have been observed in a higher-than-expected prevalence in Brazil. OBJECTIVE: To determine the frequency of thyroid carcinoma in Brazilian carriers of a founder TP53 p.R337H mutation. DESIGN, SETTING, AND PARTICIPANTS: We reviewed medical records of patients with LFS with germline TP53 p.R337H mutation. For a better understanding of the correlation between thyroid carcinoma and LFS, tumor profile data of Brazilian carriers were analyzed. We included data from 193 patients with LFS with the TP53 p.R337H mutation from the database of the Department of Oncogenetics from the A.C. Camargo Cancer Center. MAIN OUTCOMES AND MEASURES: Thyroid tumors found in this population were reviewed with regard to age at diagnosis, sex, histologic subtype, and other tumors presented by these patients. RESULTS: Overall, 101 of 193 TP53 p.R337H mutation carriers with LFS from 58 families were cancer affected and, among them, thyroid carcinoma presented a prevalence of 10.9% (3 men and 8 women). The mean age at diagnosis was 44 years (median [SD], 43 [14.77] years). All the cases were histologically classified as papillary carcinomas, with 2 of them exhibiting follicular variant. The most common other cancers in the patients with thyroid carcinoma were breast cancer (5 patients) and soft-tissue sarcoma (2 patients). CONCLUSIONS AND RELEVANCE: Thyroid carcinoma may be associated with the Brazilian founder TP53 p.R337H mutation. Knowledge about this genotype/phenotype correlation is relevant to adjusting the LFS screening recommendations to these specific carriers.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Formiga MNDC, de Andrade KC, Kowalski LP, et al. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome. JAMA Oncol. 2017. PMID: 28114597. doi:10.1001/jamaoncol.2016.6389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。